Holen Sie sich die Stockscreener-App
3.99
3.16%
-0.13
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Invesco Ltd. Grows Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Trexquant Investment LP Reduces Stock Position in Relay Therapeutics, Inc. $RLAY - MarketBeat
OMERS ADMINISTRATION Corp Makes New Investment in Relay Therapeutics, Inc. $RLAY - MarketBeat
Parkman Healthcare Partners LLC Has $493,000 Position in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics’ Promising Phase 2 Study on RLY-2608: A Potential Game-Changer in Targeted Therapy - MSN
Relay Therapeutics, Inc. $RLAY Shares Sold by Walleye Capital LLC - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Now Covered by Guggenheim - MarketBeat
Fibonacci Retracement Aligns with Support in Relay Therapeutics Inc.July 2025 Trade Ideas & Real-Time Price Movement Reports - beatles.ru
Relay Therapeutics (NASDAQ:RLAY) Trading Up 7.6%Should You Buy? - MarketBeat
Guggenheim Gives Buy Rating to Relay Therapeutics (RLAY) - Yahoo Finance
Nuveen LLC Invests $839,000 in Relay Therapeutics, Inc. $RLAY - MarketBeat
Will a bounce in Relay Therapeutics Inc. offer an exitMarket Volume Summary & Short-Term Trading Opportunity Alerts - Newser
What’s the profit margin of Relay Therapeutics Inc.July 2025 Macro Moves & Risk Controlled Swing Alerts - خودرو بانک
Is Relay Therapeutics Inc. a defensive stockEarnings Growth Summary & Long-Term Capital Growth Strategies - خودرو بانک
Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week - sharewise.com
Relay Therapeutics (RLAY) Stock Rises on Bullish Analyst Note - GuruFocus
Can Relay Therapeutics Inc. expand its profit margins2025 Winners & Losers & Weekly Top Performers Watchlists - خودرو بانک
Tools to assess Relay Therapeutics Inc.’s risk profileEarnings Performance Report & Reliable Breakout Forecasts - Newser
Pattern recognition hints at Relay Therapeutics Inc. upside2025 Key Highlights & Reliable Price Breakout Signals - Newser
What MACD signals say about Relay Therapeutics Inc.Weekly Profit Analysis & Breakout Confirmation Alerts - Newser
Real time breakdown of Relay Therapeutics Inc. stock performance2025 Volume Leaders & Verified Momentum Stock Watchlist - Newser
Predicting Relay Therapeutics Inc. trend using moving averagesMarket Performance Recap & Weekly Stock Performance Updates - Newser
Will Relay Therapeutics Inc. see short term momentumTrade Risk Summary & Long-Term Safe Investment Ideas - Newser
Relay Therapeutics (RLAY) Receives a Buy from Guggenheim - The Globe and Mail
Will Relay Therapeutics Inc. stock hit new highs in YEAR2025 Technical Patterns & AI Forecasted Entry and Exit Points - خودرو بانک
Will Relay Therapeutics Inc. continue its uptrendGlobal Markets & Technical Buy Zone Confirmations - Newser
News impact scoring models applied to Relay Therapeutics Inc.Market Growth Report & Detailed Earnings Play Alerts - Newser
Is Relay Therapeutics Inc. a momentum stock2025 Buyback Activity & AI Powered Market Entry Ideas - خودرو بانک
Guggenheim initiates Relay Therapeutics stock with Buy rating, cites strong oncology pipeline - Investing.com Canada
Momentum divergence signals in Relay Therapeutics Inc. chartWeekly Stock Recap & Consistent Growth Equity Picks - Newser
How moving averages guide Relay Therapeutics Inc. tradingWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
What does recent volatility data suggest for Relay Therapeutics Inc.2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
Can Relay Therapeutics Inc. hit a new high this monthDip Buying & Risk Controlled Stock Alerts - Newser
Relay Therapeutics Inc. stock daily chart insightsGap Up & Safe Entry Trade Signal Reports - Newser
What candlestick patterns are forming on Relay Therapeutics Inc.CPI Data & Weekly Breakout Watchlists - Newser
Published on: 2025-09-03 06:45:04 - Newser
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary - GlobeNewswire Inc.
Is Relay Therapeutics Inc. still worth holding after the dip2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Heatmap analysis for Relay Therapeutics Inc. and competitorsJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):